Evvy

New York, United States

Evvy develops at-home vaginal microbiome tests using metagenomic sequencing to understand symptoms and risks for critical health challenges.

$14.0M raised

Sep 2023

Series A

Top Investors

General CatalystBoxGroupHuman VenturesVirtueLeft Lane Capital

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Evvy raised?

Evvy has raised $14.0M in total funding. The most recent round was Series A. The last funding was announced in September 2023.

Who are Evvy's investors?

Evvy's investors include General Catalyst, BoxGroup, Human Ventures, Virtue, Left Lane Capital.

Where is Evvy headquartered?

Evvy is headquartered in New York, United States.

What does Evvy do?

Evvy develops at-home vaginal microbiome tests using metagenomic sequencing to understand symptoms and risks for critical health challenges.

What stage is Evvy at?

Evvy is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 27, 2023.

MLA

"Evvy — Funding & Investors." VCBacked, September 27, 2023, https://www.vcbacked.co/company/evvy. Accessed June 3, 2026.

APA

VCBacked. (2023). Evvy — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/evvy

Wikipedia (cite web)

{{cite web |title=Evvy — Funding & Investors |url=https://www.vcbacked.co/company/evvy |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 27, 2023.